Hector M Garcia-Garcia
Overview
Explore the profile of Hector M Garcia-Garcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
643
Citations
8580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Garcia H, Sanz-Sanchez J
JACC Cardiovasc Interv
. 2025 Mar;
18(5):634-636.
PMID: 40074519
No abstract available.
2.
Garcia-Garcia H, Kuku K, Ziemer P, Rubio P, Bulant C, Shah P, et al.
JACC Cardiovasc Interv
. 2025 Mar;
PMID: 40071320
No abstract available.
3.
Galo J, Chaturvedi A, Al-Qaraghuli A, Rubio P, Zhang C, Kahsay Y, et al.
Catheter Cardiovasc Interv
. 2025 Feb;
PMID: 39981660
Background: Intravascular ultrasound (IVUS) is essential for assessing complex coronary lesions, but remains underutilized in part due to difficulties in image interpretation. The AVVIGO IVUS Automated Lesion Assessment (ALA) software,...
4.
Gagne P, Kuku K, Mendes R, Griggs A, Segbefia E, Hofmann L, et al.
Vasc Endovascular Surg
. 2025 Feb;
:15385744251321900.
PMID: 39965864
Objective: Interventionalists have noted significant venous luminal gain with nitinol venous stents although post-placement lumen shape differed from the circular shape observed with elgiloy stents. The goal of this study...
5.
Sanz-Sanchez J, Teira Calderon A, Neves D, Cortes Villar C, Lukic A, Rumiz Gonzalez E, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941540
: Drug-eluting stents (DESs) remain the standard of treatment for patients with ST-elevation myocardial infarction (STEMI). However, complications such as stent thrombosis and in-stent restenosis still pose significant risks. Drug-coated...
6.
Yap N, Khan Z, He X, Lee J, Maung S, Morgan K, et al.
Front Cardiovasc Med
. 2025 Feb;
12:1507892.
PMID: 39925979
Accurate evaluation of coronary artery pathology is essential for risk stratification and tailoring appropriate treatment. Intravascular imaging was introduced for this purpose 40 years ago enabling for the first time...
7.
Chaturvedi A, Gadela N, Kalra K, Chandrika P, Toleva O, Alfonso F, et al.
Prog Cardiovasc Dis
. 2025 Jan;
PMID: 39880182
Ischemic heart disease is the most common cardiovascular cause of death in women worldwide. Obstructive coronary atherosclerosis is the primary cause of myocardial infarction (MI), however, non-atherosclerotic mechanisms of MI,...
8.
Mankerious N, Toelg R, Abdelghani M, Garcia-Garcia H, Farhan S, Allali A, et al.
Rev Esp Cardiol (Engl Ed)
. 2025 Jan;
PMID: 39761745
Introduction And Objectives: Patients undergoing percutaneous coronary intervention in vessels with moderate-to-severe tortuosity are at higher risk of adverse outcomes, but data are scarce in the era of newer-generation stents....
9.
Merdler I, Chaturvedi A, Case B, Hashim H, Waksman R, Garcia-Garcia H
Rev Esp Cardiol (Engl Ed)
. 2024 Nov;
PMID: 39613185
No abstract available.
10.
Abusnina W, Case B, Zhang C, Chitturi K, Sawant V, Chaturvedi A, et al.
Catheter Cardiovasc Interv
. 2024 Nov;
105(2):301-307.
PMID: 39526990
Background: Long-term clinical data on biodegradable-polymer (BP) drug-eluting stents (DES) are limited. The objective of this study was to assess the long-term safety and efficacy of the BP-DES SYNERGY compared...